Vertex Pharmaceuticals
VRTX
#138
Rank
A$178.39 B
Marketcap
$692.73
Share price
0.72%
Change (1 day)
27.43%
Change (1 year)

P/S ratio for Vertex Pharmaceuticals (VRTX)

P/S ratio as of November 2024 (TTM): 11.2

According to Vertex Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.43. At the end of 2024 the company had a P/S ratio of 11.7.

P/S ratio history for Vertex Pharmaceuticals from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202411.710.14%
202310.627.99%
20228.3012.49%
20217.38-25.49%
20209.90-27.3%
201913.6-1.82%
201813.9-8.89%
201715.241.87%
201610.7-64.24%
201530.0-39.33%
201449.5245.26%
201314.3140.39%
20125.9621.42%
20114.91-90.13%
201049.7-40.87%
200984.1243.25%
200824.557.95%
200715.5-28.9%
200621.817.27%
200518.6123.8%
20048.31-31.45%
200312.161.36%
20027.51-46.1%
200113.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.97-64.66%๐Ÿ‡บ๐Ÿ‡ธ USA
5.39-52.05%๐Ÿ‡บ๐Ÿ‡ธ USA
3.95-64.90%๐Ÿ‡บ๐Ÿ‡ธ USA
2.47-77.98%๐Ÿ‡บ๐Ÿ‡ธ USA
4.20-62.61%๐Ÿ‡บ๐Ÿ‡ธ USA
2.67-76.22%๐Ÿ‡บ๐Ÿ‡ธ USA